Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial

Published:2022-01 Issue:1 Volume:9 Page:e14-e25
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Zeiser Robert,Socié Gérard,Schroeder Mark A,Abhyankar Sunil,Vaz Carlos Pinho,Kwon Mi,Clausen Johannes,Volodin Leonid,Giebel Sebastian,Chacon Manuel Jurado,Meyers Gabrielle,Ghosh Monalisa,Deeren Dries,Sanz Jaime,Morariu-Zamfir Rodica,Arbushites Michael,Lakshminarayanan Mani,Barbour April M,Chen Yi-Bin^ORCID

Funder

Incyte Corp

Publisher

Elsevier BV

Subject

Hematology

Reference31 articles.

1. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019;Duarte;Bone Marrow Transplant,2019

2. Current use and trends in hematopoietic cell transplantation in the United States;D'Souza;Biol Blood Marrow Transplant,2020

3. Interleukin-6 as biomarker for acute GvHD and survival after allogeneic transplant with post-transplant cyclophosphamide;Greco;Front Immunol,2019

4. Risk factors for acute GVHD and survival after hematopoietic cell transplantation;Jagasia;Blood,2012

5. Improved survival after acute graft-versus-host disease diagnosis in the modern era;Khoury;Haematologica,2017

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD;Cells;2024-09-11

2. Recent advances in acute gastrointestinal graft versus host disease (aGvHD): aspects of steroid-resistant disease;Annals of Hematology;2024-08-29

3. Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide;Bone Marrow Transplantation;2024-08-24

4. Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract;Blood Advances;2024-04-26

5. Inhibition of the JAK-STAT Pathway in the Treatment of Psoriasis: A Review of the Literature;International Journal of Molecular Sciences;2024-04-25